Statera Biopharma Announces Completion of Application Proces

FORT COLLINS, CO / ACCESSWIRE / January 24, 2023 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that

Related Keywords

United States , Russia , Russian Federation , Statera Biopharma , Statera Biopharmaview , Cleveland Biolabs , Michaelk Handley , Company Or Statera Biopharma , Nasdaq , Exchange Commission , Company Annual Report On Form , European Union , Cytocom Inc , Statera Biopharma Inc , Chief Executive Officer , Annual Report , Relations Contact , Statera , Iopharma , Nnounces , Completion , Application , Process , Uplist , Tcqb , Venture , Arketplace ,